The role of infection in the development of non-valvular atrial fibrillation: Up-regulation of Toll-like receptor 2 expression levels on monocytes

Journal of Cardiology

Volumn 53, Issue 1, 2009, Pages 127-135

  Ichiki, Hitoshi ^a   Orihara, Koji ^a   Hamasaki, Shuichi ^a   Ishida, Sanemasa ^a   Oketani, Naoya ^a   Iriki, Yasuhisa ^a   Ninomiya, Yuichi ^a   Okui, Hideki ^a   Kuwahata, So ^a   Fujita, Shoji ^a   Matsushita, Takehiko ^a   Yoshifuku, Shiro ^a   Oba, Ryutaro ^b   Hirai, Hiroyuki ^b   Nagata, Kinya ^b   Tei, Chuwa ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b Kawagoe shi   (Japan)

Author keywords

C reactive protein; Infectious inflammation; Interleukin 6; Left atrial volume index; Non valvular AF; Toll like receptor 2

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 6; TOLL LIKE RECEPTOR 2;

ADULT; AGED; ARTICLE; CATHETER ABLATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HEART ATRIUM FIBRILLATION; HEART LEFT ATRIUM; HUMAN; HUMAN CELL; INFECTION; INFLAMMATION; MALE; MONOCYTE; PATHOGENESIS; PROTEIN EXPRESSION; SINUS RHYTHM; UPREGULATION;

ADULT; AGED; ATRIAL FIBRILLATION; C-REACTIVE PROTEIN; FEMALE; FLOW CYTOMETRY; HUMANS; INFECTION; INTERLEUKIN-6; MALE; MIDDLE AGED; MONOCYTES; PEPTIDE FRAGMENTS; PROCOLLAGEN; TOLL-LIKE RECEPTOR 2; UP-REGULATION;

EID: 58249144002     PISSN: 09145087     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jjcc.2008.09.008     Document Type: Article

References (29)

1. Sekiguchi A., Yamashita T., Iwasaki Y., Date T., Sagara K., Tanabe H., et al. Innate and adaptive immune reactions during progression of atrial fibrillation in humans. Jpn Circ J 72 (2008) S514
2. Anderson J.L., Allen Maycock C.A., Lappé D.L., Crandall B.G., Horne B.D., Bair T.L., et al. Frequency of elevation of C-reactive protein in atrial fibrillation. Am J Cardiol 94 (2004) 1255-1259
3. Chung M.K., Martin D.O., Sprecher D., Wazni O., Kanderian A., Carnes C.A., et al. C-reactive protein elevation in patients with atrial arrhythmias. Circulation 104 (2001) 2886-2891
4. Hatzinikolaou-Kotsakou E., Tziakas D., Hotidis A., Stakos D., Floros D., Papanas N., et al. Relation of C-reactive protein to the first onset and the recurrence rate in lone atrial fibrillation. Am J Cardiol 97 (2006) 659-661
5. Acevedo M., Corbalán R., Braun S., Pereira J., Navarrete C., and Gonzalez I. C-reactive protein and atrial fibrillation: evidence for the presence of inflammation in the perpetuation of the arrhythmia. Int J Cardiol 108 (2006) 326-331
6. Ellinor P.T., Low A., Patton K.K., Shea M.A., and MacRae C.A. C-reactive protein in lone atrial fibrillation. Am J Cardiol 97 (2006) 1346-1350
7. Gedikli O., Dogan A., Altuntas I., Altinbas A., Ozaydin M., Akturk O., et al. Inflammatory markers according to types of atrial fibrillation. Int J Cardiol 120 (2007) 193-197
8. Medzhitov R., Preston-Hurlburt P., and Janeway C.A. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388 (1997) 394-397
9. Takeuchi O., Hoshino K., Kawai T., Sanjo H., Takada H., Ogawa T., et al. Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity 11 (1999) 443-451
10. Akira S., Takeda K., and Kaisho T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol 4 (2004) 499-511
11. Pons J., Sauleda J., Regueiro V., Santos C., López M., Ferrer J., et al. Expression of Toll-like receptor 2 is up-regulated in monocytes from patients with chronic obstructive pulmonary disease. Respir Res 7 (2006) 64
12. Harter L., Mica L., Stocker R., Trentz O., and Keel M. Increased expression of toll-like receptor-2 and -4 on leukocytes from patients with sepsis. Shock 22 (2004) 403-409
13. Armstrong L., Medford A.R., Hunter K.J., Uppington K.M., and Millar A.B. Differential expression of Toll-like receptor (TLR)-2 and TLR-4 on monocytes in human sepsis. Clin Exp Immunol 136 (2004) 312-319
14. Orihara K., Nagata K., Hamasaki S., Oba R., Hirai H., Ishida S., et al. Time-couse of Toll-like receptor 2 expression as a predictor of recurrence in patients with bacterial infectious diseases. Clin Exp Immunol 148 (2007) 260-270
15. Kajiya T., Orihara K., Hamasaki S., Oba R., Hirai H., Nagata K., et al. Toll-like receptor 2 expression level on monocytes in patients with viral infections: monitoring infection severity. J Infect 57 (2008) 249-259
16. Ren J.F., Kotler M.N., DePace N.L., Mintz G.S., Kimbiris D., Kalman P., et al. Two-dimensional echocardiographic determination of left atrial emptying volume: a noninvasive index in quantifying the degree of nonrheumatic mitral regurgitation. J Am Coll Cardiol 2 (1983) 729-736
17. Mita Y., Dobashi K., Shimizu Y., Nakazawa T., and Mori M. Toll-like receptor 2 and 4 surface expressions on human monocytes are modulated by interferon-gamma and macrophage colony-stimulating factor. Immunol Lett 78 (2001) 97-101
18. Faure E., Thomas L., Xu H., Medvedev A., Equils O., and Arditi M. Bacterial lipopolysaccharide and IFN-gamma induce Toll-like receptor 2 and Toll-like receptor 4 expression in human endothelial cells: role of NF-kappa B activation. J Immunol 166 (2001) 2018-2024
19. Frustaci A., Chimenti C., Bellocci F., Morgante E., Russo M.A., and Maseri A. Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation 96 (1997) 1180-1184
20. Aikawa M., Sugiyama S., Hill C.C., Voglic S.J., Rabkin E., Fukumoto Y., et al. Lipid lowering reduces oxidative stress and endothelial cell activation in rabbit atheroma. Circulation 106 (2002) 1390-1396
21. Tveit A., Grundtvig M., Gundersen T., Vanberg P., Semb A.G., Holt E., et al. Analysis of pravastatin to prevent recurrence of atrial fibrillation after electrical cardioversion. Am J Cardiol 93 (2004) 780-782
22. Siu C.W., Lau C.P., and Tse H.F. Prevention of atrial fibrillation recurrence by statin therapy in patients with lone atrial fibrillation after successful cardioversion. Am J Cardiol 92 (2003) 1343-1345
23. Dernellis J., and Panaretou M. Relationship between C-reactive protein concentrations during glucocorticoid therapy and recurrent atrial fibrillation. Eur Heart J 25 (2004) 1100-1107
24. Hara H., Nakamura M., Yokouchi I., Kimura K., Nemoto N., Ito S., et al. Impact of statin therapy on coronary intervention for non-ST elevation acute coronary syndrome with decreased low-density lipoprotein cholesterol. J Cardiol 49 (2007) 115-123
25. Ahn K.O., Lim S.W., Li C., Yang H.J., Ghee J.Y., Kim J.Y., et al. Influence of angiotensin II on expression of toll-like receptor 2 and maturation of dendritic cells in chronic cyclosporine nephropathy. Transplantation 83 (2007) 938-947
26. Dasu MR, Riosvelasco AC, Jialal I. Candesartan inhibits Toll-like receptor expression and activity both in vitro and in vivo. Atherosclerosis 2008 [Epub ahead of print].
27. Niessner A., Steiner S., Speidl W.S., Pleiner J., Seidinger D., Maurer G., et al. Simvastatin suppresses endotoxin-induced upregulation of toll-like receptors 4 and 2 in vivo. Atherosclerosis 189 (2006) 408-413
28. D' Ambrosio A., Patti G., Manzoli A., Sinagra G., Di Lenarda A., Silvestri F., et al. The fate of acute myocarditis between spontaneous improvement and evolution to dilated cardiomyopathy: a review. Heart 85 (2001) 499-504
29. Tops L.F., Bax J.J., Zeppenfeld K., Jongbloed M.R., van der Wall E.E., and Schalij M.J. Effect of radiofrequency catheter ablation for atrial fibrillation on left atrial cavity size. Am J Cardiol 97 (2006) 1220-1222